Aguiar, P., Roitberg, F., Lopes, G., & del Giglio, A. (2020). Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System. J Bras Pneumol.
Citación estilo ChicagoAguiar, Pedro, Felipe Roitberg, Gilberto Lopes, y Auro del Giglio. "Distinct Models to Assess the Cost-effectiveness of EGFR-tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer in the Context of the Brazilian Unified Health Care System." J Bras Pneumol 2020.
Cita MLAAguiar, Pedro, Felipe Roitberg, Gilberto Lopes, y Auro del Giglio. "Distinct Models to Assess the Cost-effectiveness of EGFR-tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer in the Context of the Brazilian Unified Health Care System." J Bras Pneumol 2020.